688098 申联生物
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-0.1492.1114.1077.6659.670
总资产报酬率 ROA (%)-0.1391.9703.8157.0808.745
投入资产回报率 ROIC (%)-0.1482.0984.0797.6039.287

边际利润分析
销售毛利率 (%)61.02370.83375.22975.73183.687
营业利润率 (%)-3.96911.98022.89635.90343.642
息税前利润/营业总收入 (%)-4.09911.72122.39834.70443.748
净利润/营业总收入 (%)-3.5499.90118.55629.14438.305

收益指标分析
经营活动净收益/利润总额(%)50.23785.004103.27990.13884.436
价值变动净收益/利润总额(%)-16.75015.9604.4429.59010.216
营业外收支净额/利润总额(%)0.2040.403-0.917-2.1481.733

偿债能力分析
流动比率 (X)7.5587.8207.2576.4617.498
速动比率 (X)6.1606.3596.0715.5506.826
资产负债率 (%)5.6595.4536.7427.8507.805
带息债务/全部投入资本 (%)-0.039-0.1680.018-0.191--
股东权益/带息债务 (%)-256,793.368-59,367.630540,213.360-51,981.35666,608.363
股东权益/负债合计 (%)1,647.9211,712.6371,383.2681,178.6061,181.363
利息保障倍数 (X)33.847-38.060-77.237-78.109-65.901

营运能力分析
应收账款周转天数 (天)300.164296.208204.417141.7820.000
存货周转天数 (天)293.415464.908483.748361.2810.000